NewsDialy
AstraZeneca agreed to pay $34 million to settle allegations brought by the Texas attorney general that the pharmaceutical company paid kickbacks to improperly influence prescriptions covered by Texas Medicaid.
The settlement resolves claims that AstraZeneca used a network of free nurses and insurance support services as a vehicle for boosting sales of its medicines at the expense of the state health care program.
What a Kickback Looks Like in Practice A kickback, in this context, does not mean a cash envelope. It means something of value given to a prescriber in exchange for writing more prescriptions.
Texas alleged that AstraZeneca provided physicians with a free network of nurses and insurance support staff — services that a doctor's office would otherwise have to hire and pay for directly.
Keep reading